Use of a sensitive chemiluminescence-based assay to evaluate the metabolic suppression activity of linezolid on methicillin-resistant Staphylococcus aureus showing reduced susceptibility to vancomycin

Journal of Microbiology and Biotechnology

Volumn 19, Issue 7, 2009, Pages 734-741

  Komatsu, Mitsutaka ^a   Tajima, Yutaka ^a,b   Ito, Teruyo ^a   Yamashiro, Yuichiro ^a   Hiramatsu, Keiichi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Chemiluminescence; Linezolid; Susceptibility test; Vancomycin intermediate Staphylococcus aureus

Indexed keywords

ERYTHROMYCIN; HABEKACIN; LINEZOLID; MINOCYCLINE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM ISOLATION; BROTH DILUTION; CHEMOLUMINESCENCE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; METABOLIC INHIBITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SENSITIVITY AND SPECIFICITY; STRAIN DIFFERENCE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CHEMILUMINESCENT MEASUREMENTS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OXAZOLIDINONES; PROTEIN SYNTHESIS INHIBITORS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 70849135663     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0805.262     Document Type: Article

References (22)

1. Clinical and Laboratory Standards Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing, 15th Informational Supplement M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Clinical and Laboratory Standards Institute. 2006. Performance Standards for Antimicrobial Susceptibility Testing, 16th Informational Supplement M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Cui, L., X. Ma, K. Sato, K. Okuma, F. C. Tenover, E. M. Mamizuka, et al. 2003. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microb. 41: 5-14.
4. Diekema, D. J. and R. N. Jones. 2001. Oxazolodinone antibiotics. Lancet 258: 1975-1982.
5. Dumitrescu, O., S. Boisset, C. Badiou, M. Bes, Y. Benito, M. E. Reverdy, F. Vandenesch, J. Etienne, and G. Lina. 2007. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob. Agents Chemother. 51: 1515-1519.
6. Fridkin, S. K., J. Hageman, L. K. McDougal, J. Mohammed, W. R. Jarvis, T. M. Perl, F. C. Tenover, and the Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. 2003. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin. Infect. Dis. 36: 429-439.
7. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40: 135-136.
8. Hiramatsu, K. 1998. Vancomycin resistance in staphylococci. Drug Res. Updates 1: 135-150.
9. Komatsu, M., Y. Tajima, T. Ito, Y. Yamashiro, and K. Hiramatsu. 2008. Time-suppression test using a colorimetric probe (alamarBlue) that measures bacterial metabolic activity. Biomed. Res. 29: 171-173.
10. Manome, I., M. Ikedo, Y. Saito, K. K. Ishii, and M. Kaku. 2003. Evaluation of a novel automated chemiluminescent assay system for antimicrobial susceptibility testing. J. Clin. Microbiol. 41: 279-284.
11. Moise, P. A., A. Forrest, M. C. Birmingham, and J. J. Schentag. 2002. The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin. J. Antimicrob. Chemother. 50: 1017-1026.
12. Nagasawa, Z., I. Manome, and A. Nagayama. 2004. A rapid antimicrobial susceptibility test based on chemiluminescence assay and its application to screening of genotypes in vancomycin-resistant enterococci. J. Infect. Chemother. 10: 220-226.
13. National Committee for Clinical Laboratory Standards. 2003. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 6th Ed. Approved Standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
14. Oliveira, G. A., A. M. Dell'Aquila, R. L. Masiero, C. E. Levy, M. S. Gomes, L. Cui, K. Hiramatsu, and E. M. Mamizuka. 2001. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect. Control Hosp. Epidemiol. 22: 443-448.
15. Romero-Steiner, S., W. Spear, N. Brown, P. Holder, T. Hennessy, P. Gomez De Leon, and G. M. Carlone. 2004. Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator. Clin. Diagn. Lab. Immunol. 11: 89-93.
16. Smith, T. L., M. L. Pearson, K. R. Wilcox, C. Cruz, M. V. Lancaster, B. Robinson-Dunn, et al. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med. 340: 493-501.
17. Stevens, D. L., D. Herr, H. Lampiris, J. L. Hunt, D. H. Batts, and B. Hafkin. 2002. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 34: 1481-1490.
18. Stevens, D. L., B. Dotter, and K. Madaras-Kelly. 2004. A review of linezolid: The first oxazolidinone antibiotic. Expert Rev. Anti Infect. Ther. 2: 51-59.
19. Tajima, Y., M. Komatsu, T. Ito, and K. Hiramatsu. 2007. Rapid detection of Staphylococcus aureus strains having reduced susceptibility to vancomycin using a chemiluminescence-based drug-susceptibility test. J. Microbiol. Methods 70: 434-441. (Pubitemid 47302147)
20. - production by Escherichia coli cells: Application of rapid chemiluminescent assay to antimicrobial susceptibility testing. Microbiol. Immunol. 45: 333-340.
21. Walsh, T. R. and R. A. Howe. 2002. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu. Rev. Microbiol. 56: 657-675.
22. Zurenko, G. E., J. K. Gibson, D. L. Shinabarger, P. A. Aristoff, C. W. Ford, and W. G. Tarpley. 2001. Oxazolidinones: A new class of antibacterials. Curr. Opin. Pharmacol. 1: 470-476.